Qicong Mai

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Song Chen, Zhiqiang Wu, Feng Shi et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study

Dongdong Xia, Wei Bai, Enxin Wang et al. · Liver Cancer · 2022 · 42 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study

Xiaohong Xie, Liqiang Wang, Ying-Qing Li et al. · Frontiers in Immunology · 2022 · 35 citations · Full text

Life Sciences, Immunology, Oncology +13

Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria

Feng Shi, Shanshan Lian, Qicong Mai et al. · European Radiology · 2020 · 29 citations

Medicine, Oncology, Surgery +11

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study

Song Chen, Feng Shi, Zhiqiang Wu et al. · Journal of Hepatocellular Carcinoma · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +16